Drug intelligence / Profile preview

PFKFB3 overexpressing lentiviral vector

Development stage
Preclinical
Modality
Gene Therapies
Administration
Subcutaneous
01

Overview

PFKFB3 overexpressing lentiviral vector is a genetic construct used in preclinical research to deliver and increase the expression of the PFKFB3 gene in target cells. PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3) is a critical regulator of glycolytic metabolism, responsible for synthesizing fructose-2,6-bisphosphate, which allosterically activates phosphofructokinase-1 (PFK-1). In the context of oncology, particularly castration-resistant prostate cancer (CRPC), overexpression of PFKFB3 is associated with metabolic reprogramming that drives tumor cell proliferation, invasion, and malignant progression. Mechanistically, PFKFB3 has been shown to modulate the PI3K/Akt and Wnt/beta-catenin signaling pathways. This lentiviral tool is primarily utilized to study the oncogenic role of PFKFB3 and to validate it as a potential therapeutic target for metabolic-targeted therapies.

Other names
PFKFB3 lentivirusPFKFB-3 lentivirusPFKFB 3 lentivirusLentiviral-PFKFB3Lentiviral-PFKFB-3Lentiviral-PFKFB 3PFKFB3-overexpressing lentivirusPFKFB-3-overexpressing lentivirusPFKFB 3-overexpressing lentivirus
02

Targets

PFKFB3

Beyond the preview

Go deeper on PFKFB3 overexpressing lentiviral vector.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PFKFB3 overexpressing lentiviral vector.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call